eMedevents
  • 146,925+ Medical Conferences
  • 284 Specialties
  • 10,932 Organizers
  • 154,868 Speakers
  • 156 Countries
  • 4,693 Cities
48,975+
CME Conference Registrations Sold
Home  >  Speakers  >  Robert Michael Tuttle
Robert Michael Tuttle

Robert Michael Tuttle

    MD
Professor | New York, New York    United States of America
Endocrinology, Metabolism And Diabetes
Endocrinology, Metabolism And Diabetes,...More
Spoken at 11 events
Speaking at 2 events

Biography :

Dr. R Michael Tuttle, an Endocrinologist and Professor of Medicine at Memorial Sloan Kettering Cancer Center in New York, designed and validated the first real-time risk assessment model for thyroid cancer management in which individual risk estimates are modified over time as a function of response to initial therapy. In addition, his clinical studies have helped to define defined the role of recombinant human TSH as an adjuvant for radioactive iodine therapy in both low risk and high-risk patients and in the setting of radioactive iodine avid distant metastases.

His research continues to center on important management aspects of thyroid cancer including efforts to better define the risk of recurrence, the risk of death, and the potential role for observation in low-risk thyroid cancer. His clinical practice is entirely devoted to patients with thyroid cancer with a particular emphasis on cases with aggressive disease and complicated management issues.

*****************
************
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Endocrinology, Metabolism and Diabetes

Interested Topics

Endocrinology, Metabolism and Diabetes, Head and Neck Cancer, Thyroid Cancer Management, Radioactive Iodine Therapy, Risk Assessment

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English
Close

Send Message